Brief: Ligand Hosts 2024 Investor And Analyst Day And Introduces 2025 Guidance

Ligand Pharmaceuticals Incorporated

10/12/2024 14:05

Dec 10 (Reuters) - Ligand Pharmaceuticals  LGND.O :
    * LIGAND HOSTS 2024 INVESTOR AND ANALYST DAY AND INTRODUCES
2025
GUIDANCE
    * LIGAND PHARMACEUTICALS INC -2025 FULL YEAR REVENUE
GUIDANCE OF
$180 MILLION TO $200 MILLION
    * LIGAND PHARMACEUTICALS INC - OUTLOOK 2025 FULL YEAR CORE
ADJUSTED EARNINGS PER DILUTED SHARE OF $6.00 TO $6.25
    * LIGAND PHARMACEUTICALS INC -WILL REITERATE ITS 2024
GUIDANCE
OUTLINED IN NOVEMBER

Source text:  ID:nBwcgVMZNa 
Further company coverage:  LGND.O 

 ((Reuters.Briefs@thomsonreuters.com;))